BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15842644)

  • 21. Bilateral micropapillary serous carcinoma of the ovary: a case report.
    Gupta R; Singh S; Nigam S
    Arch Gynecol Obstet; 2007 May; 275(5):401-4. PubMed ID: 17031658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serous papillary adenocarcinoma and adult granulosa cell tumor in the same ovary. An unusual case.
    Ozbey C; Erdogan G; Pestereli HE; Simsek T; Karaveli S
    APMIS; 2005 Oct; 113(10):713-5. PubMed ID: 16309432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pelvic washing cytology in serous borderline tumors of the ovary using ThinPrep: are there cytologic clues to detecting tumor cells?
    Sadeghi S; Ylagan LR
    Diagn Cytopathol; 2004 May; 30(5):313-9. PubMed ID: 15108228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
    Ayhan A; Guven S; Guven ES; Kucukali T
    Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of serum and tissular expression of CA 125 antigen, in evaluation of the response to second line chemotherapy for the relapsed ovarian carcinoma.
    Bădulescu F; Bădulescu A; Schenker M; Popescu CF; Stoica Z
    Rom J Morphol Embryol; 2005; 46(4):329-34. PubMed ID: 16688372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testicular plasmacytoma: a case report and review of the literature.
    Wang YM; Li FY; Luo JD; Li J; Xie LP; Yang GS
    Chin Med J (Engl); 2008 May; 121(10):956-8. PubMed ID: 18706213
    [No Abstract]   [Full Text] [Related]  

  • 27. Hobnail-like cells in serous borderline tumor do not represent concomitant incipient clear cell neoplasms.
    Ohishi Y; Oda Y; Kurihara S; Kaku T; Yasunaga M; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
    Hum Pathol; 2009 Aug; 40(8):1168-75. PubMed ID: 19368953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
    Comin CE; Saieva C; Messerini L
    Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Well-differentiated serous neoplasms of the ovary.
    Longacre TA; Kempson RL; Hendrickson MR
    Pathology (Phila); 1993; 1(2):255-306. PubMed ID: 9420921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraparenchymal serous papillary cystadenoma of the testis: a case report.
    Olla L; Di Naro N; Puliga G; Tolu GA
    Pathologica; 2013 Feb; 105(1):15-7. PubMed ID: 23858946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of intratesticular endometrioid papillary cystadenocarcinoma.
    Numakura K; Tsuchiya N; Tsuruta H; Obara T; Saito M; Inoue T; Narita S; Horikawa Y; Satoh S; Nanjyo H; Habuchi T
    Jpn J Clin Oncol; 2011 May; 41(5):674-6. PubMed ID: 21474549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extraovarian peritoneal serous papillary carcinoma: a case report.
    Veroni S; Terzopoulou K; Anagnostopoulou I; Vassilakaki T; Grammatoglou X; Rammou R
    Acta Cytol; 2010; 54(5 Suppl):879-84. PubMed ID: 21053561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serous papillary cystadenocarcinoma in supernumerary ovary.
    Nomelini RS; Oliveira LJ; Jammal MP; Adad SJ; Murta EF
    J Obstet Gynaecol; 2013 Apr; 33(3):324. PubMed ID: 23550880
    [No Abstract]   [Full Text] [Related]  

  • 34. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
    Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
    Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal change disease in a patient with ovarian papillary serous carcinoma.
    Ryu DR; Yoo TH; Kim YT; Jeong HJ; Cho NH; Kang SW
    Gynecol Oncol; 2004 May; 93(2):554-6. PubMed ID: 15099980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
    Wen YH; Yee H; Goswami S; Shukla PS
    Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Papillary cystadenoma of the epididymis: a report of two cases with an immunohistochemical study.
    Calder CJ; Gregory J
    Histopathology; 1993 Jul; 23(1):89-91. PubMed ID: 7690009
    [No Abstract]   [Full Text] [Related]  

  • 38. [Uterine papillary serous carcinoma: report of a case].
    Dai L; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):557-8. PubMed ID: 20021972
    [No Abstract]   [Full Text] [Related]  

  • 39. CA125 and thyroglobulin staining in papillary carcinomas of thyroid and ovarian origin is not completely specific for site of origin.
    Keen CE; Szakacs S; Okon E; Rubin JS; Bryant BM
    Histopathology; 1999 Feb; 34(2):113-7. PubMed ID: 10064389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian-type papillary serous cystadenocarcinoma of the testis.
    Delahunt B; Nacey JN
    Br J Urol; 1996 Jan; 77(1):156-7. PubMed ID: 8653294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.